Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 6

From BugSigDB


Needs review

Curated date: 2024/11/08

Curator: KateRasheed

Revision editor(s): KateRasheed

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Mus musculus
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Response to anti-tuberculosis drug Response to anti-tuberculosis drug,response to anti-tuberculosis drug
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Untreated Tuberculosis group(TB)
Group 1 name Corresponds to the case (exposed) group for case-control studies
TB +HRZ group - 2weeks(W6)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
TB +HRZ group - 2weeks(W6) refers to the group of mice infected with Mycobacterium tuberculosis (H37Rv) by aerosol inhalation, that started isoniazid-rifampin-pyrazinamide (HRZ) treatment two weeks after infection.
Group 0 sample size Number of subjects in the control (unexposed) group
3
Group 1 sample size Number of subjects in the case (exposed) group
4

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
decreased

Signature 1

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 5: Figure S5

Description: Differentially abundant taxa between the TB and TB + HRZ groups at 2weeks post infection.

Abundance in Group 1: increased abundance in TB +HRZ group - 2weeks(W6)

NCBI Quality ControlLinks
Tannerella
Erysipelotrichaceae
Anaerorhabdus
Thomasclavelia
Anaerosporobacter
Eggerthia
Anaeroplasma
Brenneria
Prolixibacter

Revision editor(s): KateRasheed

Signature 2

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 5: Figure S5

Description: Differentially abundant taxa between the TB and TB + HRZ groups at 2weeks post infection.

Abundance in Group 1: decreased abundance in TB +HRZ group - 2weeks(W6)

NCBI Quality ControlLinks
Christensenella
Mitsuokella
Parvibacter
Gordonibacter
Oxobacter
Pseudobacteroides
Sporobacter
Butyricicoccus
Marvinbryantia
Robinsoniella
Halomonas
Alkaliphilus
Acetivibrio
Stomatobaculum
Dorea
Tyzzerella
Ruminococcus
Syntrophococcus
Romboutsia
Peptococcus
Clostridium
Turicibacter
Bacteroides

Revision editor(s): KateRasheed